Combined actions of zinc and fluoxetine on nicotinic acetylcholine receptors
- 7 September 2004
- journal article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 4 (6), 388-393
- https://doi.org/10.1038/sj.tpj.6500275
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Effect of berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cellsJournal of Pharmacy and Pharmacology, 2003
- Nicotine and nicotinic receptor antagonists potentiate the antidepressant‐like effects of imipramine and citalopramBritish Journal of Pharmacology, 2003
- Nicotinic acetylcholine receptors as targets for antidepressantsMolecular Psychiatry, 2002
- Antagonism of nicotinic acetylcholine receptors by inhibitors of monoamine uptakeMolecular Psychiatry, 2001
- Zinc co‐localizes with GABA and glycine in synapses in the lamprey spinal cordJournal of Comparative Neurology, 2001
- Modulatory role of presynaptic nicotinic receptors in synaptic and non-synaptic chemical communication in the central nervous systemBrain Research Reviews, 1999
- Blockage of Mouse Muscle Nicotinic Receptors by Serotonergic CompoundsExperimental Physiology, 1999
- Prozac (fluoxetine, lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publicationLife Sciences, 1995
- Ligands, Receptor Models, and EvolutionAnnals of the New York Academy of Sciences, 1995
- Blockage of nicotinic acetylcholine receptors by 5‐hydroxytryptamineJournal of Neuroscience Research, 1993